These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2005-003324-19 STEP ONE –trial (Study on the Treatment of Elderly Patients with Older and Newer antiepileptic drugs) - trial: A multicentre, double-blind, randomized, phase IV clinical trial comparing the safety, t... 2011-08-31 due-trials
Ongoing 2005-004437-18 Placebo-controlled double-blind study about the effectiveness of longtime acetylsalicylic acid desactivation therapy as prevention of recurrens of poyposis nasi in case of acetylsalicylic acid intole... not-yet-due
Not reported 2005-004492-37 Untersuchung über den Einfluss einer Omega-3 reichen parenteralen Ernährung auf die zelluläre Abwehr an postoperativen Patienten 2007-07-24 due-trials
Ongoing 2005-005347-25 Impact of 12 weeks of oral niacin on endothelial function, lipid composition and cardiovascular biomarkers in patients with coronary artery disease: A prospective, randomized, double-blind, placebo-co... not-yet-due
Completed, but no date 2006-000208-17 An open-label, non-randomized phase II trial of cetuximab in combination with irinotecan and 5-FU/FA for patients with metastatic gastric cancer bad-data
Not reported Terminated 2006-000475-16 Prospective, randomized, open, crossover, patient preference study comparing oral immediate release and transdermal oxybutynin in overactive bladder patients 2009-02-17 due-trials
Not reported 2006-000476-33 An open-label, multicenter phase II trial of Sunitinib for patients with chemo-refractory metastatic gastric cancer 2009-08-20 due-trials
Ongoing 2006-000511-26 Change of the inspiratory peak flow after bronchial dilatation on patients with median to severe chronic obstruktiv lung disease not-yet-due
Ongoing 2006-004533-15 Effect of 8 weeks oral Pentaerithrityltetranitrate on endothelial dysfunction in patients with coronary artery disease: A prospective, randomized, double-blind, placebo-controlled, monocentric clin... not-yet-due
Not reported 2006-005025-31 Efficacy and Safety of St. John´s Wort/Valerian Extract (Sedariston Concentrate) versus Placebo in Children and Adolescents with Attention Deficit/Hyperactivity Disorder (ADHD) 2010-03-08 due-trials
Not reported 2006-005500-14 A Randomized, Open-label, Multicenter, Efficacy and Safety Study Examining the Effects on Viral Kinetics of All-trans Retinoic Acid (Tretinoin) (VESANOID®)in Combination with PEG-IFN alfa 2a (PEGASYS... 2011-02-23 due-trials
Not reported Terminated 2006-006566-42 Sorafenib in Resected NSCLC (SIRN) - A Phase II Study to Investigate the Efficacy and Safety of Sorafenib as Adjuvant Treatment following Resection of Non-small Cell Lung Carcinoma (NSCLC) in Patients... 2008-07-15 due-trials
Not reported 2007-005796-34 A randomized, double-blind, multicenter phase II trial with gemcitabine plus sorafenib versus gemcitabine plus placebo in patients with chemo-naive advanced or metastatic adenocarcinoma of the biliary... 2011-07-20 due-trials
Not reported 2008-002123-93 Mycophenolate sodium in Graves’ orbitopathy 2015-10-12 due-trials
Not reported Terminated 2008-003285-26 Effect of methylphenidate formulation on ADHD-patients' adherence to medical treatment. A comparison of Medikinet retard® (ER) once daily and Medikinet® (IR) twice daily in children and adolescents di... 2014-12-31 due-trials
Not reported 2008-003966-25 Double-blind, placebo controlled, randomised, monocenter cross-over studie to evaluate the effect of Desmopressin on the nocturnal polyuria in patients with idiopathic Parkinson Syndrome compared to p... 2010-12-10 due-trials
Not reported 2008-005828-84 Inflammatory mediators in nasal discharge of chronic rhinosinusitis patients treated with erythromycin. 2012-07-17 due-trials
Not reported 2008-006381-29 Neoadjuvant, sequential chemotherapy with docetaxel followed by Fluorouracil, Epirubicin, and Cyclophosphamid every 3 weeks - genome wide expression analysis for identification of a predictive gene si... 2014-11-01 due-trials
Not reported 2008-008280-96 Randomised clinical trial comparing early medication change (EMC) strategy with treatment as usual (TAU) in patients with Major Depressive Disorder – the EMC trial. 2014-04-30 due-trials
Not reported 2009-011881-27 Changes of cerebral spinal fluid APPSα levels under oral therapy with acitretin 30 mg daily in patients with mild to moderate Alzheimer’s disease: a multicenter prospective randomised placebo-controll... 2013-05-15 due-trials
Ongoing 2009-012108-15 Korrelation von freiem IgE mit klinischen Parametern bei Asthma-Patienten unter Therapie mit Omalizumab, einem monoklonalen Antikörper gegen körpereigenes IgE not-yet-due
Not reported 2009-013351-30 A phase I/II trail to evaluate the safety, feasibility and efficacy of the addition of temsirolimus (Torisel™) to a regimen of bendamustine and rituximab for the treatment of patients with follicular ... 2017-04-05 due-trials
Not reported 2009-014336-38 A randomized, placebo-controlled phase II trial investigating SUNITINIB versus placebo in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus treated with chemother... 2013-07-01 due-trials
Not reported Terminated 2009-015537-67 Untersuchung der Wirksamkeit und Sicherheit von Vareniclin in der Postakutbehandlung der Alkoholabhängigkeit - eine prospektive, bizentrische, doppelblinde, placebokontrollierte, randomisierte Phase I... 2013-10-04 due-trials
Not reported 2009-017010-68 A TElmisartan and AMlodipine STudy to Assess the cardiovascular PROTECTive effects as measured by endothelial dysfunction in hypertensive at risk patients beyond blood pressure 2011-08-29 due-trials
Not reported 2010-019715-38 Placebokontrollierte, prospektive Beobachtung des Schmerzempfindens bei Probanden während der mechanischen Epilation mit dem Braun Expressive Epilationsgerät nach Auftragen von Lokaltherapeutika (Emla... 2010-10-20 due-trials
Reported results 2010-019885-10 Non-randomized phase-IV-study to investigate the efficacy of FOLFIRI in combination with cetuximab in the first-line treatment of metastatic colorectal cancer inculding a regular dermal prophylaxis to... 2017-07-09 due-trials
Not reported 2010-019975-30 Investigation of the efficacy and safety of preoperative IOP reduction with preservative-free COSOPT-S® (dorzolamide/timolol, MSD) eye drops versus oral acetazolamide and dexamethasone eye drops and a... 2014-04-23 due-trials
Not reported 2010-021369-66 Investigation of pharmacokinetics of Ciprofloxacin and Piperacillin/Tazobactam in Patients receiving continuous renal replacement therapy 2012-12-18 due-trials
Not reported Terminated 2010-021782-70 Open monocentric clinical pilot study in COPD und Asthma patients to investigate static as well as dynamic ventilation, intrapulmonary ADC and pO2 using helium-3-MRI after inhalation of hyperpolarise... 2014-11-07 due-trials
Completed, but no date 2010-022840-19 A monocentric, randomized, placebo-controlled double-blind clinical trial to assess the efficacy of Selenium in Morbus Basedow bad-data
Listed as ongoing, but also has a completion date and reported results 2011-000218-20 LICC: L-BLP25 in Patients with Colorectal Carcinoma after curative resection of hepatic metastases – a randomized, placebo-controlled, multicenter, multinational, double blinded phase II trial 2018-01-24 bad-data
Not reported 2011-002812-10 A prospective, randomised, open-label phase IIb clinical trial assessing the effect of pegylated Interferon alfa-2a (Pegasys®) 180 µg once weekly for 48 weeks in addition to an ongoing nucelos(t)ide b... 2017-08-28 due-trials
Not reported Terminated 2011-005305-73 Effects of clopidogrel vs prasugel vs ticagrelor on endothelial function, inflammatory and oxidative stress parameters and platelet function in patients undergoing coronary artery stenting. A randomis... 2016-02-24 due-trials
Ongoing 2013-000899-16 Investigation of pharmacokinetics of Linezolid and Meropenem in patients receiving continuous renal replacement therapy not-yet-due
Other 2013-001657-28 Home Treatment of Patients with Low-Risk Pulmonary Embolism with the Oral Factor Xa Inhibitor Rivaroxaban: Prospective Management Trial (HoT-PE) not-yet-due
Not reported 2013-003352-20 Correlation of functional and structural outcomes with serum antibody profiles in patients with neovascular age-related macular degeneration treated with ranibizumab and healthy subjects: a prospectiv... 2017-11-09 due-trials
Completed, report not yet due Terminated 2013-005364-26 Resolution of Left Atrial-Appendage Thrombus – Effects of Dabigatran in patients with AF (RE-LATED AF) – A Prospective, multicenter, randomized, open-label, controlled, explorative, blinded-endpoint (... 2018-05-22 not-yet-due
Not reported Terminated 2014-002363-15 EVITA Trial: Effect of VItamin D as add-on Therapy for vitamin D insufficient patients with severe Asthma: a randomized, double-blind, placebo-controlled trial. 2017-04-03 due-trials
Ongoing 2014-004780-21 GOAL trial: Rescue treatment with the monoclonal anti CD20-antibody Obinutuzumab (GA101) in combination with PixantrOne for the treatment of patients with relapsed Aggressive B-cell Lymphoma not-yet-due
Ongoing 2015-001830-12 Safety and Efficacy of Low Molecular Weight Heparin for 72 Hours Followed by Dabigatran for the Treatment of Acute Intermediate-Risk Pulmonary Embolism. not-yet-due
Completed, but no date Terminated 2015-001868-19 A randomized, double-blind, placebo-controlled, mono-center study to evaluate the effects of mepolizumab on airway physiology in patients with eosinophilic asthma: the MEMORY study bad-data
Completed, but no date Terminated 2016-000284-17 Phase II study of metronomic treatment with daily oral vinorelbine as first-line chemotherapy in patients with advanced/metastatic HR+/HER2- breast cancer resistant to endocrine therapy (VinoMetro). bad-data
Ongoing 2016-001264-11 A phase IV, single-center, randomized, double-blind, placebo-controlled, parallel group study on the effects of empagliflozin on left ventricular diastolic function compared to usual care in individua... not-yet-due
Ongoing 2016-004373-40 A phase II, open-label, multicenter trial to investigate the clinical activity and safety of avelumab in patients with advanced, metastatic high grade neuroendocrine carcinomas NEC G3 (WHO 2010) progr... not-yet-due
Exempt 2017-002468-41 A phase I/II multicenter, open-label Study of DKN-01 to investigate the anti-tumor activity and safety of DKN-01 in Patients with Hepatocellular Carcinoma and WNT signaling Alterations not-yet-due